$GRCE
Grace Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.04
▼-2.86%-$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateGrace Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is GRCE down today? It is at $2.04 (-2.86%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GRCE spikes, and full due diligence on GRCE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GRCE 3 times in the last 30 days. Create a free account to track $GRCE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GRCE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GRCE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +2K | added <0.1% | 2.86M | $3K at $2.06 | Oct 5, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +20K 0.10% of company | added 0.7% | 2.86M | $41K at $2.07 | Oct 2, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +39K 0.2% of company | added 1.4% | 2.84M | $79K at $2.04 | Oct 1, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +8K 0.04% of company | added 0.3% | 2.80M | $16K at $2.09 | Sep 29, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +5K 0.03% of company | added 0.2% | 2.86M | $11K at $2.10 | Sep 23, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +10K 0.05% of company | added 0.3% | 2.85M | $21K at $2.10 | Sep 21, 26 |
Kohli Prashant Officer | Bought (open market) | +100K 0.5% of company | added 100% | 121K | $214K at $2.14 | Sep 9, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +6K 0.03% of company | added 0.2% | 2.78M | $12K at $2.09 | Sep 9, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +9K 0.04% of company | added 0.3% | 2.77M | $20K at $2.10 | Sep 8, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +12K 0.06% of company | added 0.4% | 2.76M | $24K at $2.09 | Aug 14, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on GRCE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GRCE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GRCE last traded at $2.04, down 2.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Grace Therapeutics, Inc. Common Stock (GRCE) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GRCE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GRCE 3 times in the last 30 days.
GRCE (Grace Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $43M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GRCE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GRCE discussion
Sign in to ask a question or join the discussion.